FRALEY MARK E has a total of 17 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are EPIGEN BIOSCIENCES INC, SCHIEMANN KAI and BOEHRINGER INGELHEIM ITALIA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 14 | |
#2 | United States | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Fraley Mark E | 17 |
#2 | Hartman George D | 6 |
#3 | Garbaccio Robert M | 5 |
#4 | Hoffman William F | 5 |
#5 | Hungate Randall W | 3 |
#6 | Hambaugh Scott R | 2 |
#7 | Kim Yuntae | 2 |
#8 | Steen Justin T | 2 |
#9 | Subramanian Raju | 1 |
#10 | Prueksaritanont Thomayant | 1 |
Publication | Filing date | Title |
---|---|---|
WO2004111193A2 | Prodrugs of mitotic kinesin inhibitors | |
WO2004087050A2 | Mitotic kinesin inhibitors |